Clinical Trial Update: SALT Study (Switching to the Administration of Lithium Slow -Release Treatment) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the SALT study evaluating switching to slow-release lithium treatment in bipolar disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium slow-release (SALT study) treatment (lithium)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Bipolar Disorder | Phase 4 | Status: TERMINATED